The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVRP.L Share News (VRP)

  • There is currently no data for VRP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Small caps round-up: Transense Tech, Hightex, Verona Pharma

Tue, 28th Aug 2012 14:43

Transense Technologies, which provides sensor systems for the transportation and industrial markets, has reported that its trading division, Translogik, has received an initial order for its iTrack Tyre Temperature and Pressure Monitoring Systems for mining and off-the-road vehicles from its Indonesian distributor, AutoRFID Solutions. The system will be installed as part of a pilot scheme on three of the 168 vehicles at the ADARO mine in Indonesia, one of AutoRFID's clients. Graham Storey, Chief Executive Officer of Transense, said it is "very encouraging that our success in South Africa has triggered this order in what is a new territory for us".Hightex Group, a systems engineering company, has been selected, along with its Brazilian construction partner SEPA, to engineer and install the membrane structure of the roof of the Beira-Rio Stadium in Porto Alegre, a 2014 FIFA World Cup venue. The deal, which has a value in the region of €10m, marks the firm's second contract win in Brazil. The stadium is the fifth largest in Brazil, and will accommodate around 50,000 spectators. Work will begin immediately and is due to be completed in 2013. Verona Pharma, a drug discovery company, has been granted a new patent for its lead drug candidate, RPL554, in the US. The product is being developed for the treatment of patients with chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma. The company is currently carrying out clinical trials of the drug to further characterise its bronchodilator and anti-inflammatory effects. NR
More News
9 Jun 2015 14:36

AGM, EGM Calendar - Week Ahead

Read more
9 Jun 2015 05:28

AGM, EGM Calendar - Week Ahead

Read more
8 Jun 2015 14:56

AGM, EGM Calendar - Week Ahead

Read more
8 Jun 2015 06:49

Verona Pharma Says Study Shows RPL554 Well Tolerated

Read more
8 Jun 2015 05:33

AGM, EGM Calendar - Week Ahead

Read more
5 Jun 2015 15:03

AGM, EGM Calendar - Week Ahead

Read more
5 Jun 2015 05:21

AGM, EGM Calendar - Week Ahead

Read more
4 Jun 2015 15:22

AGM, EGM Calendar - Week Ahead

Read more
22 May 2015 13:01

DIRECTOR DEALINGS SUMMARY: Glencore Non-Executive Cuts Stake

Read more
18 May 2015 14:03

DIRECTOR DEALINGS: Verona Pharma Directors Buy Shares

Read more
12 May 2015 16:22

Verona Pharma's loss widens on extended development costs

Verona Pharma posted a widened pre-tax loss for 2014 in the run up to its lead compound's commercial development. The company posted a pre-tax loss of £3.8m for 2014, up from £2.8m a year earlier, as research costs swelled from £1.7m to £2.6m over the period. Development bore a new commercial formu

Read more
12 May 2015 10:30

Verona Loss Widens As It Continues Lead Compound Development

Read more
12 May 2015 05:18

Earnings, Trading Statements Calendar - Week Ahead

Read more
11 May 2015 14:56

Earnings, Trading Statements Calendar - Week Ahead

Read more
11 May 2015 05:34

Earnings, Trading Statements Calendar - Week Ahead

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.